Quick Answer
SINOVAC BIOTECH LTD reported Net Income Loss of -$99.92 million for the year ending 2023.
- SINOVAC BIOTECH LTD showed a decrease of -187.8% in Net Income Loss from 2022 to 2023.
- This data is from SINOVAC BIOTECH LTD's annual report (Form 10-K), filed with the SEC on April 29, 2024.
- XBRL data for this metric is available from 2009 to 2023 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 10 years of available data (2009 to 2023), SINOVAC BIOTECH LTD's Net Income Loss has declined by 600.6%.
- Historical annual values: Fiscal year 2023: -$99.92 million | Fiscal year 2022: $113.87 million | Fiscal year 2021: $8.47 billion | Fiscal year 2020: $110.37 million | Fiscal year 2019: $44.93 million | Fiscal year 2018: $21.78 million | Fiscal year 2017: $25.81 million | Fiscal year 2011: -$844.7 thousand | Fiscal year 2010: -$8.51 million | Fiscal year 2009: $19.96 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: